BMO Capital Maintains Outperform on AMN Healthcare Services, Raises Price Target to $43

BMO Capital analyst Jeffrey Silber has maintained an 'Outperform' rating on AMN Healthcare Services (NYSE: AMN) and increased the price target from $40 to $43.